
|Articles|December 1, 1997
The American Journal of Managed Care
- December 1997
- Volume 3
- Issue 12
Adverse Drug Reactions: A Review for Healthcare Practitioners
Advertisement
Articles in this issue
almost 28 years ago
Gastrointestinal Illness in Managed Care: Healthcare Utilization and Costsalmost 28 years ago
Recognition and Treatment of Patients in the Persistent Vegetative StateNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy
2
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
3
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
4
The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD
5














































